Topic: Pharmaceuticals Sector

Walgreen, others sue Pfizer over depression drug

(Reuters) - Pfizer Inc and Teva Pharmceutical Industries Ltd were sued by Walgreen Co and four other large retailers, accused of violating U.S. antitrust law by conspiring to keep generic versions of a popular antidepressant off the shelves.Walgreen, Kroger Co, Safeway Inc, ...

Facebook apologizes for Merck homepage mix-up

(Reuters) - Facebook Inc said on Monday that it made a mistake in letting Merck & Co take over a page on the social networking website from its German rival Merck KGaA.The takeover prompted an unusual November 21 filing by Merck KGaA ...

Merck said to hijack German rival's Facebook page

(Reuters) - German drugmaker Merck KGaA accused U.S. rival Merck & Co of hijacking its Facebook page and said it plans to sue to get it back.Merck KGaA asked a New York judge to force Facebook Inc to turn over information to ...

Merck fined $950 mn over painkiller marketing

Pharmaceutical giant Merck will pay nearly $1 billion to resolve criminal and civil charges for wrongfully marketing its former hit painkiller Vioxx, the US Department of Justice said.Merck agreed to plead guilty to breaking the Food, Drug, and Cosmetic Act after it ...

FDA warns Mylan on Puerto Rico plant violations

(Reuters) - U.S. drug regulators found "significant violations" of manufacturing regulations at Mylan Inc's Caguas, Puerto Rico, facility, according to a letter posted on Tuesday.A Food and Drug Administration inspection earlier this year found that the generic drugmaker failed to complete a ...

UK lawmakers to probe medicine shortages

LONDON (Reuters) - A continuing shortage of some essential medicines in Britain is to be investigated by members of parliament, following complaints by pharmacists that vital supplies are being lost to exports.The All-Party Pharmacy Group, which announced its inquiry on Monday, said ...

Returns on R&D tumble at world's top drugmakers

LONDON (Reuters) - Investment returns from researching new drugs have fallen nearly 30 percent in the past year at the world's 12 top pharmaceutical companies, highlighting the productivity dilemma facing the sector, according to a report on Monday.The average internal rate of ...

Novartis unit pays $150 million to end drug-price dispute

ZURICH (Reuters) - Novartis' Sandoz unit has agreed to pay $150 million Swiss francs to settle claims it charged the U.S. and state governments inflated prices for drugs, a Swiss newspaper reported on Sunday.Under the deal Novartis will pay the U.S. government ...

U.S. doctors group supports fight on drug shortages

NEW ORLEANS (Reuters) - The American Medical Association threw its support behind government efforts to ensure the supply of lifesaving medicines but stopped short of recommending financial penalties against drug companies.The influential doctors' lobby voted on Monday to back legislation to create ...

No need for new cost cut plan at Roche: chairman

ZURICH (Reuters) - Swiss drugmaker Roche Holding AG does not need a new cost cutting program after it announced a big savings plan last year, Chairman Franz Humer told a newspaper on Sunday."We don't need new programs... but we will always pursue ...